NFKB1 and hepatocellular carcinoma: This has been elegantly demonstrated in the case of the transcription factor NF-κB. Work by Karin et al. demonstrated that in the setting of hepatocellular carcinoma, activation of NF-κB in hepatocytes is protective against developing cancer [8, 9], whereas activation in macrophages promotes cancer progression [10].